• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket

    4/12/24 5:32:49 AM ET
    $ADIL
    $ALLR
    $APLD
    $BENF
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADIL alert in real time by email

    Shares of NextPlat Corp (NASDAQ:NXPL) rose sharply in today’s pre-market trading after the company reported consolidated 2023 revenues of $37.8 million, up 222% year over year

    NextPlat shares surged 29.8% to $1.96 in pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

     

    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) shares rose 100.8% to $4.62 in pre-market trading after dipping 29% on Thursday. Allarity Therapeutics filed prospectus supplement to increase offering price of common stock that may be offered from $1.4 million to $2.4 million.
    • PaxMedica, Inc. (NASDAQ:PXMD) gained 77.2% to $0.7353 in pre-market trading after the company announced the completed execution of its three pivotal registration/validation batches of PAX-101.
    • OncoCyte Corporation (NASDAQ:OCX) shares gained 42.3% to $4.27 in pre-market trading. Oncocyte priced its $15.8 million private placement of securities priced at-the-market under Nasdaq rules.
    • Zapata Computing Holdings Inc. (NASDAQ:ZPTA) climbed 31.2% to $3.29 in pre-market trading after gaining over 5% on Thursday.
    • AMTD Digital Inc. (NYSE:HKD) shares gained 26.5% to $4.01 in pre-market trading.
    • Beneficient (NASDAQ:BENF) rose 24.3% to $0.0859 in pre-market trading after dipping around 10% on Thursday.
    • Draganfly Inc. (NASDAQ:DPRO) gained 17.3% to $0.2898 in pre-market trading. Draganfly will showcase cutting-edge drone technologies at XPONENTIAL 2024 in San Diego.
    • Assure Holdings Corp. (NASDAQ:IONM) shares rose 14.1% to $0.7879 in pre-market trading after falling 6% on Thursday.
    • Hycroft Mining Holding Corporation (NASDAQ:HYMC) shares gained 11.6% to $4.73 in pre-market trading after surging 25% on Thursday.


    Losers

     

    • Motus GI Holdings, Inc. (NASDAQ:MOTS) fell 24.3% to $0.3199 in pre-market trading after the company announced that it does not believe that it will be able to maintain the listing of its common stock on the Nasdaq and that it does not intend to appeal the staff's determination. The company said it is exploring a range of strategic and financing alternatives.
    • Rent the Runway, Inc. (NASDAQ:RENT) fell 17.4% to $16.00 in pre-market trading. Rent the Runway shares jumped 162% on Thursday after the company reported mixed fourth-quarter financial results and issued guidance.
    • Kazia Therapeutics Limited (NASDAQ:KZIA) shares fell 16.2% to $0.3018 in pre-market trading after dipping 14% on Thursday.
    • Monogram Orthopaedics, Inc. (NASDAQ:MGRM) shares declined 15.2% to $3.45 in pre-market trading. Monogram shares jumped 79% on Thursday after the company announced it joined the NVIDIA Inception program.
    • Marin Software Incorporated (NASDAQ:MRIN) declined 11.4% to $0.5322 in pre-market trading. Marin Software shares fell around 8% on Thursday after the company announced upgrades to its integration with Microsoft Advertising..
    • Rallybio Corporation (NASDAQ:RLYB) fell 10.7% to $2.66 in pre-market trading. Rallybio shares jumped around 83% on Thursday after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT..
    • Applied Digital Corporation (NASDAQ:APLD) fell 9.1% to $2.79 pre-market trading after the company reported worse-than-expected third-quarter financial results.
    • Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) shares fell 9.3% to $2.11 in pre-market trading. Adial Pharmaceuticals shares jumped 106% on Wednesday after the company announced the publication of a peer-reviewed article highlighting the clinical results, strong safety profile, and high compliance among patients administered AD04.
    • MOGU Inc. (NYSE:MOGU) fell 10.3% to $1.90 in pre-market trading after declining around 8% on Thursday.
    • Nurix Therapeutics, Inc. (NASDAQ:NRIX) fell 6.3% to $16.12 pre-market trading after the company priced its upsized $175m public offering of 10,166,667 common shares at $15 per share.

    Now Read This: Citigroup, JPMorgan And 3 Stocks To Watch Heading Into Friday

     

    Get the next $ADIL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADIL
    $ALLR
    $APLD
    $BENF

    CompanyDatePrice TargetRatingAnalyst
    Nurix Therapeutics Inc.
    $NRIX
    1/8/2026$36.00Equal-Weight → Overweight
    Morgan Stanley
    Applied Digital Corporation
    $APLD
    1/7/2026$99.00Buy
    Arete
    Nurix Therapeutics Inc.
    $NRIX
    11/24/2025$30.00Buy
    Truist
    Draganfly Inc.
    $DPRO
    11/5/2025$19.00Buy
    Ladenburg Thalmann
    Draganfly Inc.
    $DPRO
    10/30/2025$20.00Buy
    Needham
    Nurix Therapeutics Inc.
    $NRIX
    10/21/2025$24.00Outperform
    Mizuho
    Applied Digital Corporation
    $APLD
    9/15/2025Buy
    Compass Point
    Allarity Therapeutics Inc.
    $ALLR
    7/28/2025$9.00Buy
    Ascendiant Capital Markets
    More analyst ratings

    $ADIL
    $ALLR
    $APLD
    $BENF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Nurix Therapeutics upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Nurix Therapeutics from Equal-Weight to Overweight and set a new price target of $36.00

    1/8/26 8:12:12 AM ET
    $NRIX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Arete initiated coverage on Applied Digital with a new price target

    Arete initiated coverage of Applied Digital with a rating of Buy and set a new price target of $99.00

    1/7/26 9:08:58 AM ET
    $APLD
    Finance: Consumer Services
    Finance

    Truist resumed coverage on Nurix Therapeutics with a new price target

    Truist resumed coverage of Nurix Therapeutics with a rating of Buy and set a new price target of $30.00

    11/24/25 9:17:24 AM ET
    $NRIX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADIL
    $ALLR
    $APLD
    $BENF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Sprott Eric bought $4,085,000 worth of shares (100,000 units at $40.85) (SEC Form 4)

    4 - HYCROFT MINING HOLDING CORP (0001718405) (Issuer)

    3/6/26 4:11:40 PM ET
    $HYMC
    Precious Metals
    Basic Materials

    Large owner Sprott Eric bought $4,758,000 worth of shares (100,000 units at $47.58) (SEC Form 4)

    4 - HYCROFT MINING HOLDING CORP (0001718405) (Issuer)

    3/5/26 4:27:05 PM ET
    $HYMC
    Precious Metals
    Basic Materials

    SEC Form 4 filed by Executive Chair Fonseca Dhiren R.

    4 - Rent the Runway, Inc. (0001468327) (Issuer)

    3/3/26 4:47:54 PM ET
    $RENT
    Other Specialty Stores
    Consumer Discretionary

    $ADIL
    $ALLR
    $APLD
    $BENF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Sprott Eric bought $4,085,000 worth of shares (100,000 units at $40.85) (SEC Form 4)

    4 - HYCROFT MINING HOLDING CORP (0001718405) (Issuer)

    3/6/26 4:11:40 PM ET
    $HYMC
    Precious Metals
    Basic Materials

    Large owner Sprott Eric bought $4,758,000 worth of shares (100,000 units at $47.58) (SEC Form 4)

    4 - HYCROFT MINING HOLDING CORP (0001718405) (Issuer)

    3/5/26 4:27:05 PM ET
    $HYMC
    Precious Metals
    Basic Materials

    Large owner Sprott Eric bought $6,307,500 worth of shares (150,000 units at $42.05) (SEC Form 4)

    4 - HYCROFT MINING HOLDING CORP (0001718405) (Issuer)

    2/23/26 6:34:48 PM ET
    $HYMC
    Precious Metals
    Basic Materials

    $ADIL
    $ALLR
    $APLD
    $BENF
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Draganfly Inc.

    SCHEDULE 13G - Draganfly Inc. (0001786286) (Subject)

    3/6/26 5:13:04 PM ET
    $DPRO
    Aerospace
    Industrials

    SEC Form 8-K filed by Nurix Therapeutics Inc.

    8-K - Nurix Therapeutics, Inc. (0001549595) (Filer)

    3/6/26 4:40:45 PM ET
    $NRIX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 424B5 filed by Nurix Therapeutics Inc.

    424B5 - Nurix Therapeutics, Inc. (0001549595) (Filer)

    3/6/26 4:38:38 PM ET
    $NRIX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADIL
    $ALLR
    $APLD
    $BENF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Allarity Therapeutics Closes $20 Million Financing to Accelerate the Advance of Stenoparib Toward FDA Approval and Commercialization

             Extends Company Cash Runway into Mid-2028Financing Expected to Fund Completion of Phase 2 Ovarian Cancer TrialFinancing Supports Acceleration Toward Pivotal Trial and CommercializationFinancing Structured as Non-Convertible Debt Financing TARPON SPRINGS, Fla., March 6, 2026 – Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ:ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib (2X-121)—a differentiated, dual PARP and WNT pathway inhibitor—today announced that it has closed a $20 million non-convertible debt financing with Streeterville Capital. The transaction is structured as a note purchase agreement pursuant to which the Com

    3/6/26 8:00:00 AM ET
    $ALLR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Adial Pharmaceuticals Reports 2025 Fiscal Year Financial Results and Provides Business Update

    GLEN ALLEN, Va., March 06, 2026 (GLOBE NEWSWIRE) --  Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today provided a business update and reported its financial results for the 2025 fiscal year ended December 31, 2025. Key Highlights: Regulatory Progress: Achieved positive clinical study results from the AD04-103 pharmacokinetics (PK) study supporting AD04's pharmacologic profile and regulatory strategy.Received a positive response from the U.S. Food and Drug Administration (FDA) regarding the Company's proposed in vitro bri

    3/6/26 8:00:00 AM ET
    $ADIL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Applied Digital Announces Pricing of $2.15 Billion of Senior Secured Notes to fund Polaris Forge 2 Campus

    DALLAS, March 04, 2026 (GLOBE NEWSWIRE) -- Applied Digital Corporation (NASDAQ:APLD) ("Applied Digital" or the "Company"), a leading designer, builder and operator of high-performance, sustainably engineered data centers and colocation services for Artificial Intelligence ("AI"), networking, and blockchain workloads, today announced that its subsidiary, APLD ComputeCo 2 LLC ("APLD Compute 2"), has priced a $2.15 billion offering (the "Offering") of 6.750% senior secured notes due 2031 (the "Notes") at an issue price of 98%. The Notes will be sold in a private offering to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act of 19

    3/4/26 7:00:00 AM ET
    $APLD
    Finance: Consumer Services
    Finance

    $ADIL
    $ALLR
    $APLD
    $BENF
    Leadership Updates

    Live Leadership Updates

    View All

    Draganfly Welcomes Lieutenant-General (Ret'd) Michel Gauthier to Military Advisory Board in Support of Canada's Defence Industrial Strategy

    Ottawa, ON, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ:DPRO, CSE:DPRO, FSE: 3U8A)) ("Draganfly" or the "Company"), an award-winning developer of drone solutions, software, and robotics, today announced the appointment of Lieutenant-General (Ret'd) Michel Gauthier to its Military Advisory Board. The appointment comes as Canada advances its renewed Defence Industrial Strategy, a national framework focused on strengthening sovereign defence production, accelerating innovation, modernizing procurement, and reducing reliance on foreign supply chains. Lieutenant-General Gauthier brings more than 36 years of distinguished service with the Canadian Armed Forces. He served as Comman

    2/20/26 8:30:00 AM ET
    $DPRO
    Aerospace
    Industrials

    Applied Digital Appoints Co-Founder Jason Zhang as President

    DALLAS, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Applied Digital (NASDAQ:APLD), a designer, builder, and operator of high-performance, sustainably engineered data centers and colocation services for artificial intelligence, cloud, networking, and blockchain workloads, today announced the appointment of its co-founder and current Chief Strategy Officer, Jason Zhang, as the company's President. As one of the founders of Applied Digital, Mr. Zhang has been instrumental in fueling the company's innovation, working closely with co-founder Wes Cummins. The appointment reflects the role Mr. Zhang has long played in shaping the company's strategy and long-term growth trajectory. As President, Mr. Zhang

    1/15/26 8:00:00 AM ET
    $APLD
    Finance: Consumer Services
    Finance

    Draganfly Drones Deployed with Search and Rescue Sweden

    SASKATOON, SK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ:DPRO, CSE:DPRO, FSE: 3U8A)) ("Draganfly" or the "Company"), an award-winning, industry-leading drone solutions and systems developer, is pleased to announce the deployment of Draganfly drones integrated with Smith Myers, ARTEMIS Mobile Phone Detection & Location Systems (MPDLS) for search and rescue operations. Search and Rescue Sweden, one of Europe's foremost search-and-rescue (SAR) organizations, will deploy Draganfly UAS platforms outfitted with Smith Myers ARTEMIS, specifically engineered for the SAR market, to provide cost-effective, high-performance aerial support for missing-person recoveries, wilderness rescu

    1/13/26 8:30:00 AM ET
    $DPRO
    Aerospace
    Industrials

    $ADIL
    $ALLR
    $APLD
    $BENF
    Financials

    Live finance-specific insights

    View All

    Babcock & Wilcox Reports Fourth Quarter and Full Year 2025 Results

    Revenue, Operating Income and EBITDA all ahead of street expectations Revenue in fourth quarter of $161.0 million Operating income in the fourth quarter of $12.2 million, compared to operating income of $2.6 million in the same period of 2024 Adjusted EBITDA from Continuing Operations in the fourth quarter of $16.4 million, a 53% increase compared to the same period of 2024 Parts & services revenues increased 17% in 2025, continuing to outperform expectations due to increased coal generation usage and higher baseload demand in North America Paid off outstanding bonds due February 2026 in December 2025 Signed full notice to proceed for a $2.4 billion AI data center project

    3/4/26 6:30:00 AM ET
    $APLD
    $BW
    Finance: Consumer Services
    Finance
    Building Products
    Industrials

    Rallybio Corporation and Candid Therapeutics Announce Merger Agreement

    Combined company to operate as Candid Therapeutics, advancing a leading portfolio of T-cell engager therapeutics for autoimmune diseases Concurrent significantly oversubscribed and upsized financing of over $505 million committed by a syndicate of leading healthcare institutional investors and mutual funds expected to fund operations through 2030 Companies to hold joint conference call on March 2, 2026 at 8:30 AM ET Rallybio Corporation (NASDAQ:RLYB) ("Rallybio") and Candid Therapeutics, Inc. ("Candid"), a global clinical-stage biotechnology company advancing a leading portfolio of T-cell engager ("TCE") therapeutics for autoimmune diseases, today announced that they have entered into

    3/2/26 8:00:00 AM ET
    $RLYB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    NextPlat Expects Approximately $55 Million in 2025 Revenue and Reports Strong Sequential Momentum with Cost Reductions and Margin Expansion Expected into 2026

    Improved Cash Flow and Operational Profitability Goals for 2026 Supported by Early Q1 Momentum in High-Margin 340B, Expansion of Higher-Margin Contracted Services, and Continued Growth in E-Commerce RevenueHALLANDALE BEACH, Fla., Feb. 25, 2026 /PRNewswire/ -- NextPlat Corp (NASDAQ:NXPL, NXPLW), NXPLW) ("NextPlat" or the "Company"), a global consumer products and services company providing healthcare and technology solutions through e-commerce and retail channels worldwide, today announced that it expects to report sequential improvement in key financial and operational metrics for the fourth quarter ended December 31, 2025 compared to the third quarter, reflecting continued progress from its

    2/25/26 8:01:00 AM ET
    $NXPL
    Telecommunications Equipment
    Telecommunications

    $ADIL
    $ALLR
    $APLD
    $BENF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Oncocyte Corporation

    SC 13G/A - Oncocyte Corp (0001642380) (Subject)

    12/9/24 5:30:06 PM ET
    $OCX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Amendment: SEC Form SC 13D/A filed by Applied Digital Corporation

    SC 13D/A - Applied Digital Corp. (0001144879) (Subject)

    11/29/24 4:20:07 PM ET
    $APLD
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13G/A filed by AMTD Digital Inc.

    SC 13G/A - AMTD Digital Inc. (0001809691) (Subject)

    11/14/24 9:33:22 PM ET
    $HKD
    Finance: Consumer Services
    Finance